OAM
BHC icon

Oppenheimer Asset Management’s Bausch Health BHC Stock Holding History

Oppenheimer Asset Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-46,030
Closed -$385K – 1123
2022
Q2 		$385K Sell
46,030
-6,850
-13% -$95.8K 0.01% 920
2022
Q1 		$1.21M Buy
52,880
+32
+0.1% +$782 0.02% 691
2021
Q4 		$1.46M Sell
52,848
-2,067
-4% -$55.3K 0.02% 653
2021
Q3 		$1.53M Sell
54,915
-2,118
-4% -$60.1K 0.02% 612
2021
Q2 		$1.67M Buy
57,033
+619
+1% +$18.8K 0.02% 590
2021
Q1 		$1.79M Sell
56,414
-102
-0.2% -$2.99K 0.03% 542
2020
Q4 		$1.18M Buy
56,516
+11,916
+27% +$222K 0.02% 636
2020
Q3 		$693K Buy
44,600
+14,708
+49% +$253K 0.01% 718
2020
Q2 		$547K Buy
29,892
+15,886
+113% +$280K 0.01% 780
2020
Q1 		$217K Sell
14,006
-29,279
-68% -$706K 0.01% 950
2019
Q4 		$1.29M Buy
+43,285
New +$1.13M 0.03% 557
2017
Q2 		– Sell
-2,092
Closed -$23K – 1670
2017
Q1 		$23K Buy
+2,092
New +$28.8K ﹤0.01% 1459

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Oppenheimer Asset Management's BHC Position: Q3 2022 in Review

Oppenheimer Asset Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 46,030 shares — an estimated $385K sold.

Oppenheimer Asset Management first reported a position in BHC in Q1 2017 and held it in 12 quarters. The position peaked at $1.79M in Q1 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Oppenheimer Asset Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 46,030 Bausch Health shares in Q3 2022, an estimated $385K.
  • Oppenheimer Asset Management first reported a position in Bausch Health in Q1 2017 and held it in 12 quarters.
  • Oppenheimer Asset Management's Bausch Health position peaked at $1.79M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Oppenheimer Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.